ReviewJournal of the Korean Society of Radiology2026
Cardiac CT for the Assessment of Ischemic Cardiomyopathy.
Review in Journal of the Korean Society of Radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Preface to the Special Issue on 'Pragmatic Cardiovascular Imaging'].Journal of the Korean Society of Radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic cardiomyopathy is a major cause of heart failure, and the accurate assessment of myocardial ischemia, infarction, and tissue characteristics is essential for therapeutic decision-making. Cardiac CT provides integrated structural and functional information by enabling coronary anatomical evaluation, as well as assessment of left ventricular volume, ejection fraction, and regional wall motion. CT myocardial perfusion imaging enables the evaluation of hemodynamically significant ischemia, whereas late iodine enhancement CT directly visualizes myocardial infarction and fibrosis. Dual-energy CT improves contrast resolution and quantitative analysis, supporting enhanced myocardial tissue characterization such as extracellular volume estimation. CT-derived fractional flow reserve complements the physiological assessment of coronary stenosis, and integrating these findings with perfusion, scarring, tissue composition, and functional parameters improves the differentiation between ischemic and non-ischemic cardiomyopathies. With these advances, cardiac CT has evolved into a multiparametric platform for myocardial evaluation. This review summarizes its role in ischemic cardiomyopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.